XML 29 R18.htm IDEA: XBRL DOCUMENT v3.26.1
Stockholders' Equity
 3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Stockholders' Equity Stockholders’ Deficit
Common Stock

As of March 31, 2026, there were 20,000,000 shares of common stock authorized, 12,285,554 shares issued, and 12,101,150 shares outstanding. The par value for the common stock is $0.001 per share.
Stock-Based Compensation

The Company’s stock-based compensation generally includes stock options, restricted stock units (“RSUs”), performance-vesting restricted stock units (“PRSUs”), and purchases under the Company’s 2019 Employee Stock Purchase Plan (the “ESPP”). Stock-based compensation expense related to RSUs is based on the market value of the underlying stock on the date of grant and the related expense is recognized ratably over the requisite service period. The stock-based compensation expense related to PRSUs is estimated at the grant date based on the expectation that performance goals will be achieved at the stated target level. The amount of compensation cost recognized depends on the relative satisfaction of the performance condition based on performance to date. There were no PRSUs granted during the three months ended March 31, 2026, and 2025.

Stock Incentive Plans

The Company’s 2019 Stock Incentive Plan became effective on April 11, 2019. The 2019 Stock Incentive Plan, as amended and restated, allows the Company’s employees and directors to participate in the Company’s future performance through grants of stock-based awards of stock options and RSUs at the discretion of the board of directors. The number of shares authorized for issuance under the 2019 Stock Incentive Plan as of March 31, 2026 was 3,487,182 shares. Options to acquire common stock granted under the 2019 Stock Incentive Plan have ten-year terms. As of March 31, 2026, 43,123 shares of common stock remained available for issuance (taking into account all stock option exercises and other equity award settlements through March 31, 2026).

Employee Stock Purchase Plan

The number of shares authorized for issuance under the ESPP as of March 31, 2026 was 300,000 shares. As of March 31, 2026, 92,972 shares of common stock remained available for issuance under the ESPP (taking into account all share purchases through March 31, 2026).

Inducement Plan

There are 1,027,489 shares of common stock authorized and reserved for issuance under the Inducement Plan. As of March 31, 2026, 77,746 shares of common stock remained available for issuance under the Inducement Plan (taking into account all option exercises and other equity award settlements through March 31, 2026).

Stock Option Activity

The following table is a summary of the Company’s stock option activity and weighted average exercise prices for the three months ended March 31, 2026:
Stock Option ActivityWeighted Average Remaining Contractual Term
(In years)		Aggregate Intrinsic Value
(In thousands)
Options
(In thousands)		Weighted
Average
Exercise Price
Balance outstanding at December 31, 2025178 $184.30 5.92$— 
Granted— — 
Exercised— — 
Cancelled or expired(2)461.55 
Balance outstanding at March 31, 2026176 180.47 5.74— 
Options vested and expected to vest 100 306.10 3.91— 
Options exercisable at March 31, 202682 $368.37 2.73$— 

The total fair value of stock options exercised during the three months ended March 31, 2026 and 2025 was immaterial. As of March 31, 2026, there was $0.4 million of total unrecognized compensation cost related to nonvested share-based compensation arrangements. That cost is expected to be recognized over a weighted average period of approximately 1.4 years.
Restricted Stock Unit and Performance-Vesting Restricted Stock Unit Activity

The following table is a summary of the Company’s RSU and PRSU activity and weighted average grant date fair value for the three months ended March 31, 2026:
Number of SharesWeighted Average Grant Date Fair ValueAggregate Fair Value
(In thousands)(Per share)(In thousands)
Balance outstanding at December 31, 2025783 $15.45 $3,028 
Awarded44 3.76 
Released(62)31.36 
Forfeited(14)25.37 
Non-vested and outstanding at March 31, 2026751 13.30 1,914 
Expected to vest 628 $13.51 $1,602 
RSUs granted to employees generally vest over a one to four-year period, or upon achievement of certain performance conditions. As of March 31, 2026, total unrecognized compensation cost, adjusted for estimated forfeitures, related to nonvested RSUs was $5.4 million and the weighted-average remaining vesting period was 0.95 years.

PRSUs granted are generally subject to both a service-based vesting condition and a performance-based vesting condition. PRSUs will vest upon the achievement of specified performance targets and subject to continued service through the applicable vesting dates. The associated compensation cost is recognized over the requisite service period when it is probable that the performance condition will be satisfied. There were no PRSUs granted during the three months ended March 31, 2026 and 2025, respectively. The PRSUs that vested in the third quarter of 2025 were settled and distributed during the three months ended March 31, 2026.

Total stock-based compensation costs included in the condensed consolidated statements of operations for the three months ended March 31, 2026 and 2025 are as follows:

Three Months Ended March 31,
20262025
(In thousands)
Cost of revenue $81 $186 
Sales and marketing 507 1,378 
General and administrative 1,153 1,773 
Product development 521 1,372 
Total$2,262 $4,709